Medicare Enrolled

Dr. Edward Mena, M.D.

Hepatology Physician · Pasadena, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
301 S FAIR OAKS AVE STE 405, Pasadena, CA 91105
6264407325
In practice since 2006 (20 years)
NPI: 1881654226 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mena from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mena? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mena

Dr. Edward Mena is a hepatology physician in Pasadena, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mena performed 1,246 Medicare services across 1,027 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mena received a total of $579,674 from 48 pharmaceutical and/or device companies across 1477 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hepatology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mena is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 18% volume in CA $579,674 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,246
Medicare services
Top 18% in CA for hepatology physician
1,027
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~62 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
518 $70 $150
Ultrasound scan of organ tissue for measuring elasticity
This procedure uses ultrasound technology to assess the stiffness or elasticity of organ tissues. It helps evaluate tissue characteristics without invasive methods.
278 $85 $425
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
273 $102 $225
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
78 $92 $320
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
53 $131 $450
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
29 $44 $105
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
17 $144 $325
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$579,674
Total received (2018-2024)
Avg $82,811/year across 7 years
Top 0% in CA for hepatology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
1,477
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$537,768 (92.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$36,131 (6.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,776 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$130,158
2023
$68,057
2022
$73,378
2021
$67,358
2020
$48,915
2019
$88,172
2018
$103,636

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$38,927
Ipsen Biopharmaceuticals, Inc
$28,636
Madrigal Pharmaceuticals
$23,930
Lilly USA, LLC
$22,093
ABBVIE INC.
$8,374
Eisai Inc.
$5,038
Intercept Pharmaceuticals, Inc.
$2,138
Boston Scientific Corporation
$202
Sirtex Medical Inc
$189
FUJIFILM Healthcare Americas Corporation
$163
ORPHALAN INC
$123
HISTOSONICS,INC.
$75
Genentech USA, Inc.
$74
Mirum Pharmaceuticals, Inc.
$64
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$63
Mallinckrodt Hospital Products Inc.
$32
Genentech, Inc.
$23
Novo Nordisk Inc
$15
Top 3 companies account for 70.3% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$184,627
Intercept Pharmaceuticals, Inc.
$56,446
AbbVie, Inc.
$54,766
INTERCEPT PHARMACEUTICALS, INC.
$40,906
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$35,863
Ipsen Biopharmaceuticals, Inc
$32,226
Madrigal Pharmaceuticals
$23,930
Eisai Inc.
$23,095
Lilly USA, LLC
$22,141
EISAI INC.
$19,945
ABBVIE INC.
$17,964
Dova Pharmaceuticals
$14,130
Echosens North America, Inc.
$12,926
AbbVie Inc.
$12,686
E.R. Squibb & Sons, L.L.C.
$8,565
Merck Sharp & Dohme Corporation
$4,044
Shionogi Inc
$3,553
Bayer HealthCare Pharmaceuticals Inc.
$2,282
ALBIREO PHARMA, INC.
$2,208
Mallinckrodt Hospital Products Inc.
$2,149
PFIZER INC.
$1,161
AstraZeneca Pharmaceuticals LP
$1,040
Amarin Pharma Inc.
$485
Alexion Pharmaceuticals, Inc.
$408
Allergan Inc.
$254
Genentech USA, Inc.
$241
FUJIFILM Healthcare Americas Corporation
$202
Boston Scientific Corporation
$202
Sirtex Medical Inc
$189
PORTOLA PHARMACEUTICALS, INC.
$150
Sobi, Inc
$144
Mirum Pharmaceuticals, Inc.
$144
ORPHALAN INC
$123
Alnylam Pharmaceuticals Inc.
$92
HISTOSONICS,INC.
$75
Takeda Pharmaceuticals U.S.A., Inc.
$67
KADMON PHARMACEUTICALS LLC
$43
W. L. Gore & Associates, Inc.
$27
GENZYME CORPORATION
$23
Genentech, Inc.
$23
Exelixis Inc.
$21
Allergan, Inc.
$20
QOL Medical, LLC
$19
AMAG Pharmaceuticals, Inc.
$17
Novo Nordisk Inc
$15
Ortho Dermatologics, a division of Bausch Health US, LLC
$14
Retrophin, Inc.
$14
Travere Therapeutics, Inc.
$10
Top 3 companies account for 51.0% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ANDEXXA · Bylvay · CABOMETYX · CREON · CUVRIOR · CYRAMZA · Cholbam · DOPTELET · Doptelet · Epclusa · FERAHEME · FibroScan · Fibroscan · GIVLAARI · GORE CARDIOFORM Septal Occluder · IMFINZI · IQIRVO · KANUMA · KEYTRUDA · Kanuma · LENVIMA · LINZESS · Lenvima · Livdelzi · Livmarli · MAVYRET · MOUNJARO · Mavyret · Mulpleta · Nexavar · OCALIVA · OPDIVO · PAXLOVID · RESMETIROM · REZDIFFRA · SIR-Spheres Microspheres · SUCRAID · SYNAGIS · Stivarga · TECENTRIQ · TERLIVAZ · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · UTASWAKO AFP-L3 · VIBERZI · Vascepa · Vemlidy · Wegovy · XERESE · XIFAXAN · XIFIXAN · ZEPATIER · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hepatology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for hepatology physician in CA.

Looking for a hepatology physician in Pasadena?
Compare hepatology physicians in the Pasadena area by procedure volume, costs, and industry payment transparency.
Browse hepatology physicians nearby

Geographic Context

Hepatology physicians within 10 mi
15
Per 100K population
0.2
County median income
$87,760
Nearest hospital
GLENDALE ADVENTIST MEDICAL CENTER
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mena is a clinical cardiology specialist, with above-average Medicare volume (top 18% in CA), with speaking/promotional industry engagement in the top 0% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mena experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Mena performed 518 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mena receive payments from pharmaceutical companies?
Yes. Dr. Mena received a total of $579,674 from 48 companies across 1,477 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mena's costs compare to other hepatology physicians in Pasadena?
Dr. Mena's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mena) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →